POSTER SESSION VI
Wednesday, March 28, 2007 — 1:00 PM - 4:00 PM
Exhibit Hall B - 1
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt in the toolbar above as feedback:
BREAST PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
39
A Validation Study of a Molecular Assay for the Detection of Metastases in Sentinel Lymph Nodes of Breast Carcinoma Patients
(220)
G Viale, P Dell’Orto, G Mazzarol, MO Biasi, V Stufano - European Institute of Oncology - University of Milan, Milan, Italy
Combined Evaluation of Pre-Operative Imaging and DCIS Grade on Core Biopsy Indicate Sentinel Lymph Node Evaluation Is Unnecessary for Most Cases of Ductal Carcinoma In Situ
(215)
AD Tatsas, JF Simpson, CR Herman, ME Sanders - Vanderbilt University, Nashville, TN
Sentinel Lymph Node Biopsy in Breast Cancer Patients More Than 70 Years of Age
(144)
M Hulvat, K Yao, J Norton, G Aranha, PB Rajan - Loyola University Medical Center, Maywood, IL
Accuracy of Intraoperative Sentinel Lymph Node Evaluation for Breast Cancer
(195)
V Richards, DF Roses, DM Axelrod, AA Guth, RL Shapiro, J Cangiarella, N Ziguridis, F Darvishian, B Singh - New York University, New York, NY
Intraoperative Examination of Sentinel Lymph Node in Breast Cancer: A Comparative Study of Imprint Cytology and Frozen Section
(227)
DR Woods, R Johnson, S Lear, AW Martin, S Sahoo - University of Louisville, Louisville, KY
Non-Sentinel Node Status in Breast Cancer Patients with Isolated Tumor Cells in the Sentinel Node: Implications for Axillary Node Dissection
(190)
PB Rajan, E Rajan, K Yao - Loyola University Medical Center, Maywood, IL; Loyola University Cardinal Bernardin Cancer Center, Maywood, IL
Megakaryocytes in Sentinel Lymph Node May Detract from Identification of Metastatic Breast Cancer or May Be Misdiagnosed as Metastatic Carcinoma
(93)
S Bhusnurmath, L Balazs, E Pritchard, N Zafar - University of Tennessee at Memphis, Memphis, TN
Intraoperative Sentinel Lymph Node Evaluation Leads to Disparity in Treatment of Breast Cancer Patients
(83)
AB Ambaye, A Ciampa, S Naud, DL Weaver - UVM, Burlington, VT
Keratin Immunohistochemistry Does Not Contribute To Correct Lymph Node Staging in Patients with Invasive Lobular Carcinoma
(181)
DT Patil, CL Schiller, B Susnik - Northwestern University Feinberg School of Medicine, Chicago, IL
Management of the Axilla in Patients with Clinically Negative Nodes: The University of Kentucky Breast Cancer Center Experience
(143)
JL Hinson, YM Brill, JT Davis, P McGrath, A Moore, E Romond, LM Samayoa - University of Kentucky, Lexington, KY; VA Hospital, Lexington, KY
Mammaglobin, a Novel Diagnostic Marker for Metastatic Breast Carcinoma
(224)
Z Wang, B Spaulding, G Nielsen, A Sienko, Y Liang, H Li, J Ro, J Zhai - Weill College of Medicine Cornell University, The Methodist Hospital, Houston, TX; Dako North America Inc, Carpenteria, CA; Kingmed Center, Guangzhou, Guangdong, China
WT-1 Expression in Primary Invasive Breast Carcinoma: Occasional Expression in Micropapillary and Mucinous Subtypes
(151)
R Karabakhtsian, R Bhargava - University of Kentucky Medical Center, Lexington, KY; Magee-Womens Hospital of UPMC, Pittsburgh, PA
Diagnostic Value of Telomerase Expression in Breast Fine Needle Aspiration Biopsies
(120)
G Fischer, O Tutuncuoglu, M Bakhshandeh, S Masood - University of Florida HSC, Jacksonville, FL
Cyclin D1 Overexpression with CCND1 Amplification Is Correlated with Loss of BTG2 in Estrogen-Receptor Positive Human Breast Cancer
(98)
EF Brachtel, H Kawakubo, JB Kish, G Yeo, S Maheswaran - Massachusetts General Hospital, Harvard Medical School, Boston, MA
Expression of SmgGDS in Mammary Carcinomas and Its Function in Cancer Cell Migration
(229)
C Wynveen, HY Zhi, L Gruman, JK Kuhnmuench, R Thill, CL Williams, HY Yang, SK Zhu, CG Becker, R Li - Medical College of Wisconsin, Milwaukee, WI
Breast Cancer Subtypes and Clinical Characteristics of Women 30 Years or Younger
(225)
YH Wen, DF Roses, DM Axelrod, AA Guth, RL Shapiro, JF Cangiarella, P Zappile, N Ziguridis, F Darvishian, B Singh - New York University School of Medicine, New York, NY
Interleukin-8 Expression Does Not Correlate with Estrogen Receptor Status in Human Breast Cancer
(91)
M Bendre, R Hunter, D Gaddy, LJ Suva - UT Houston, Houston, TX; University of Arkansas for Medical Sciences, Little Rock, AR
Frequent Loss of TSLC1 and DAL-1 Expression in Human Breast Cancer Cell Lines and Tissues
(126)
J Geradts, G Heller, B Ziegler, I Newsham, M Filipits, E-M Markis-Ritzinger, D Kandioler, W Berger, W Stiglbauer, D Depitsch, R Pirker, C Zielinski, S Zoechbauer-Mueller - Duke University Medical Center, Durham, NC; Medical University of Vienna, Vienna, Austria; General Hospital Wiener Neustadt, Vienna, Austria; M.D. Anderson Cancer Center, Houston, TX
Tocopherol-Associated Protein Expression in Human Breast Cancer
(223)
X Wang, S Johnykutty, P Tang, P Bourne, SY Yeh - University of Rochester, Rochester, NY
Validation of Tissue Microarray Analysis in a Large Prospectively Accrued Patient Cohort of Lymph Node Negative Breast Cancer
(172)
AM Mulligan, D Pinnaduwage, SB Bull, FP O’Malley, IL Andrulis - Mount Sinai Hospital, Toronto, ON, Canada; Toronto, ON, Canada
Tertiary Center Breast Cancer Pathology Review: Positive Impact on Patient Care
(115)
LJ Elavathil, M Goulbourne, A Zaidi, N Howatt, K Ceballos, OB Tadross, G Gohla, T Aziz, B Strang, SK Dhesy-Thind, A Lytwyn - Juravinski Cancer Center, Hamilton, ON, Canada; McMaster University, Hamilton, ON, Canada
button next to any title to add to Itinerary Planner...
Add
